The Effectiveness of Eldecalcitol in the Osteoporotic Patients Who Are Bisphosphonate Non-responders After Long-term Bisphosphonate Treatment

Trial Profile

The Effectiveness of Eldecalcitol in the Osteoporotic Patients Who Are Bisphosphonate Non-responders After Long-term Bisphosphonate Treatment

Recruiting
Phase of Trial: Phase I

Latest Information Update: 22 May 2015

At a glance

  • Drugs Eldecalcitol (Primary)
  • Indications Osteoporosis
  • Focus Pharmacodynamics
  • Most Recent Events

    • 19 May 2015 Status changed from not yet recruiting to recruiting, according to to ClinicalTrials.gov record.
    • 09 Dec 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top